Yuko Nitahara

Yuko Nitahara

Auto-generated profile, based on publicly available information

Yuko Nitahara

Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
YNYu Nakagama
Yu Nakagama
YKYuko Komase
Yuko Komase
NKNatsuko Kaku
Natsuko Kaku
YNYuko Nitahara
Yuko Nitahara
ETEvariste Tshibangu-Kabamba
Evariste Tshibangu-Kabamba
YKYasutoshi Kido
Yasutoshi Kido
Past SARS-CoV-2 infection is an important determinant of protection from reinfection and of postvaccine immune responses. Our results show that different immunoassays, by design, harbor variable capability of tracking SARS-CoV-2 infection under waning antibody concentrations.

22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
YNYuko Nitahara
Yuko Nitahara
YNYu Nakagama
Yu Nakagama
NKNatsuko Kaku
Natsuko Kaku
KCKatherine Candray
Katherine Candray
YMYu Michimuko
Yu Michimuko
YKYasutoshi Kido
Yasutoshi Kido
Establishing vaccine-based population immunity has been the key factor in attaining herd protection. Thanks to expedited worldwide research efforts, the potency of mRNA vaccines against the coronavirus disease 2019 (COVID-19) is now incontestable.

16 February 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
YNYu Nakagama
Yu Nakagama
YNYuko Nitahara
Yuko Nitahara
NKNatsuko Kaku
Natsuko Kaku
ETEvariste Tshibangu-Kabamba
Evariste Tshibangu-Kabamba
YKYasutoshi Kido
Yasutoshi Kido
Serial antibody measurements using an array of SARS-CoV-2 immunoassays have demonstrated differing kinetics among assay platforms (1).…

31 October 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
YNYu Nakagama
Yu Nakagama
YKYuko Komase
Yuko Komase
KCKatherine Candray
Katherine Candray
SNSachie Nakagama
Sachie Nakagama
FSFumiaki Sano
Fumiaki Sano
YKYasutoshi Kido
Yasutoshi Kido
We describe the results of testing frontline health care workers, from a hospital in Japan that had experienced a COVID-19 outbreak, for SARS-CoV-2-specific antibodies. Antibody testing revealed that a surprising 42% of overlooked COVID-19 diagnoses occurred when case detection relied solely on PCR-based viral detection.

19 March 2021 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
TTTomoya Tsuchida
Tomoya Tsuchida
YNYuko Nitahara
Yuko Nitahara
SSShotaro Suzuki
Shotaro Suzuki
YKYuko Komase
Yuko Komase
KCKatherine Candray
Katherine Candray
TMTakahide Matsuda
Takahide Matsuda

19 July 2021 in medRxiv
Verified
Preprint
Open access
PDF file
YNYu Nakagama
Yu Nakagama
YKYuko Komase
Yuko Komase
KCKatherine Candray
Katherine Candray
SNSachie Nakagama
Sachie Nakagama
FSFumiaki Sano
Fumiaki Sano
YKYasutoshi Kido
Yasutoshi Kido
We describe the results of testing healthcare workers from a tertiary care hospital in Japan, which had experienced a COVID-19 outbreak during the first peak of the pandemic, for SARS-CoV-2 specific antibody seroconversion. Using two chemiluminescent immunoassays and a confirmatory surrogate virus neutralization test, serological testing unveiled that a surprising 42.2% (27/64) of overlooked COVID-19 diagnoses had occurred when case detection had relied solely on SARS-CoV-2 nucleic acid amplification testing. This undetected portion of the COVID-19 iceberg beneath the surface may potentially have led to silent transmissions and triggered the spread. A questionnaire-based risk assessment was further indicative of exposures to specific aerosol-generating procedures, i.e. non-invasive ventilation, having had conveyed the highest transmission risks and served as the origin of outbreak. Our observations are supportive of a multi-tiered testing approach, including the use of serological diagnostics, in order to accomplish exhaustive case detection along the whole COVID-19 spectrum.